ReviewTranslational lung cancer research2014
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it.
Christian Rolfo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled ittrialcites it